-
Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
ReShape Lifesciences
Company Profile
Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm | 1.95 mm |
Cash burn (monthly) | 353.67 k | 18.42 k | 1.62 mm | 1.86 mm | 653.67 k | 605.50 k |
Cash used (since last report) | 16.73 mm | 871.26 k | 76.47 mm | 88.03 mm | 30.92 mm | 28.64 mm |
Cash remaining | -14.79 mm | 1.07 mm | -74.52 mm | -86.09 mm | -28.98 mm | -26.70 mm |
Runway (months of cash) | -41.8 | 58.4 | -46.1 | -46.3 | -44.3 | -44.1 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|